Search

everythinglearnresearchcommunity

for

Search:↓

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

PRP or nanofat injections improve scar tissue quality but don't significantly boost hair transplant results for scarring hair loss.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

People who are more materialistic often expect life changes from buying things, leading to more debt and credit misuse.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Topical finasteride is an effective and safer treatment for male hair loss.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

PRP injections can increase hair density in people with androgenic alopecia.

Hydroxychloroquine may help delay skin damage in lupus patients.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Melatonin improved mental health and metabolism in women with PCOS.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

PCOS increases sexual pain distress in infertile women.

PRP is effective for treating hair loss, improving hair density, count, and thickness.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.